Royston, UK – Significant improvements in assay reagents and availability of High Throughput Screen (HTS)-compatible readers has propelled fluorescence lifetime (FLT) technology to the vanguard of cost-effective screening technologies. TTP Labtech has consolidated its position in the field with today’s announcement of the purchase of assets from AssayMetrics Limited, Cardiff, UK a leading company in […]

SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced it has entered into a multi-year licensing agreement with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, related to the use of Illumina’s next-generation sequencing technology for clinical laboratory testing. Among the terms, Quest will have broad rights to use Illumina’s sequencing and […]

FREMONT, Calif. — WaferGen Bio-systems, Inc. (QTCQB: WGBS) announced today the acquisition of the NGS library preparation business from IntegenX Inc. Pursuant to the asset purchase agreement, WaferGen Bio-systems, Inc., through Wafergen, Inc., its wholly owned subsidiary, acquired on January 6, 2014 substantially all of the assets of IntegenX’s product line used in connection with […]

Paris – Cellectis (Alternext: ALCLS), the genome engineering specialist, has announced the completion of a structurally important transaction concerning its subsidiary Cellectis bioresearch, which specializes in designing, developing and marketing products and services essentially for academic and biopharmaceutical industry researchers: a simplified legal structure, with Ectycell merged into Cellectis bioresearch; and a reinforced equity position, […]

Manassas, VA — Biomatrica®, Inc., a world leader in ambient temperature biological stabilization technologies, and ATCC, the premier global biological materials resource and standards organization, today announce the completion of a licensing agreement. According to the agreement terms, Biomatrica will supply ATCC with DNAstable® and RNAstable® reagents for the stabilization of DNA and RNA standards. […]

MENLO PARK, Calif. — SRI International has received a $4.5 million contract from the National Heart, Lung and Blood Institute, part of the National Institutes of Health, to establish a Metabolite Standards Synthesis Center to prepare molecules for researchers to use in the emerging field of metabolomics. Like genomics and proteomics, which study the collective […]

WALTHAM, Mass. — Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company (NYSE: GE), for approximately $1.06 billion. The businesses will become part […]

CHALFONT ST. GILES, UK – GE (NYSE:GE) and Thermo Fisher Scientific (NYSE:TMO) announced today that they have entered into an agreement for GE Healthcare to acquire Thermo Fisher’s HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses for approximately $1.06 billion. The acquisition will allow GE to expand its offering of […]

Watson-Marlow Pumps Group (WMPG) strengthens its single-use biopharmaceutical offering through acquisition of Bio Pure Technology Limited (Bio Pure). Watson-Marlow, a world-leading positive displacement pump manufacturer, has acquired Bio Pure through its parent company Spirax-Sarco Engineering plc for £8.5 million. Bio Pure, based in Portsmouth UK, specialises in the design and production of advanced single-use tubing […]